Virus studies in the treatment of congenital cytomegalovirus infections by cytosine arabinoside.
D003168:Complement Fixation Tests; D003561:Cytarabine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D003587:Cytomegalovirus / Q000187:drug effects* / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000276:immunology; D004361:Drug Tolerance; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007223:Infant; D007231:Infant, Newborn; D007275:Injections, Intravenous; D008297:Male
D007074:Immunoglobulin G; D007075:Immunoglobulin M; D003561:Cytarabine